3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
1
Phase 1
1
Status
Recruiting
6
Completed
6
Terminated
4
Active not recruiting
2
Withdrawn
1
Unknown
1
Enrolling by invitation
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Neoplasms
57
Breast Neoplasms
52
Leukemia, Myeloid, Acute
40
Carcinoma, Non-Small-Cell Lung
40
Lymphoma
35
Pancreatic Neoplasms
30
Leukemia, Lymphocytic, Chronic, B-Cell
30
Leukemia
30
Precursor Cell Lymphoblastic Leukemia-Lymphoma
27
Neoplasm Metastasis
27
Ovarian Neoplasms
25
Multiple Myeloma
25
Lymphoma, Non-Hodgkin
25
Recurrence
24
Lung Neoplasms
23
Melanoma
22
Lymphoma, Large B-Cell, Diffuse
21
Prostatic Neoplasms
20
Glioblastoma
20
Brain Neoplasms
19
Colorectal Neoplasms
18
Lymphoma, Follicular
17
Squamous Cell Carcinoma of Head and Neck
16
Sarcoma
16
Lymphoma, B-Cell
15
Lymphoma, Mantle-Cell
14
Myelodysplastic Syndromes
13
Urinary Bladder Neoplasms
12
Lymphoma, B-Cell, Marginal Zone
12
Glioma
12
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Withdrawn
×
Prostatic Neoplasms, Castration-Resistant
×
Clear all
NCT02866916
2021-01-20
PROSTIRNA
Institut Claudius Regaud
Phase 1
Withdrawn